secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001104659-23-119165
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

NWBO enters $11M loan with Streeterville Capital; 8% interest, 24-month maturity
--------------------------------------------------------------------------------

- Loan amount $11,005,000 from Streeterville Capital; 24-month maturity; repayments begin Nov 2024.
- Interest rate 8% per annum; 10% original issue discount; prepayment allowed with 10% charge.
- Loan amortized in 12 equal monthly installments at 110% of pro rata principal plus accrued interest.
- Proceeds used for ongoing business operations; customary default provisions included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923119165/0001104659-23-119165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923119165/tm2330851d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-119165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer